Kimia Biosciences Limited is an India-based company, which is engaged in the business of pharmaceutical products. The Company provides its products under various categories: Commercial Active Pharmaceutical Ingredients (APIs), Commercial KSMs, Intermediates & Reagents. The Company's Commercial-APIs products include acotiamide hydrochloride hydrate, azelnidipine, benfotiamine, benidipine hydrochloride, citicoline sodium, gliclazide, dapagliflozin propanediol monohydrate, levosulpiride, luliconazole, oxaceprol, prucalopride succinate, teneligliptin hydrobromide hydrate, vildagliptin, fimasartan trihydrate potassium, obeticholic acid and ursodeoxycholic acid. Its Commercial KSMs, Intermediates & Reagents products include Ethyl-2-Amino 1,3-Thiazole 4-Carboxylate, 2,4,5-Trimethoxy Benzoic Acid, Ethyl 2-(2,4,5-trimethoxybenzamido)-1,3-thiazole-4-carboxylate, Isopropyl 2-(3-Nitrobenzylidene) Acetoacetate, Choline phosphate chloride calcium, and more.
More about the company